Migraine: symptoms, causes, types, and management
A comprehensive overview of migraine disorder: typical symptoms (including aura), types (episodic vs chronic), underlying mechanisms, triggers, impact, and approaches to diagnosis and treatment.
A migraine is a recurrent neurological disorder most often recognised by a moderate-to-severe, throbbing or pounding pain that commonly affects one side of the head. Attacks typically last from a few hours up to several days and are often accompanied by nausea, vomiting, and heightened sensitivity to light, sound, and smell. Some people experience sensory disturbances called aura before or during an attack; others have migraine without head pain but with the same disabling features.
Image gallery
10 ImagesSymptoms, phases and common patterns
Migraine attacks may follow several phases, although not everyone experiences all of them. A prodrome (hours to days before pain) can include fatigue, mood change, neck stiffness, or food cravings. The headache phase is usually unilateral and pulsatile, often worsening with physical activity. Associated symptoms frequently include nausea, dizziness and sensory sensitivity. In some cases an aura precedes the headache: visual changes such as flashing lights, zigzag lines or blind spots are typical, but auras can also affect speech, movement or sensation. Attacks commonly last between four and 72 hours when untreated.
Types and diagnostic distinctions
Migraines are classified by their frequency and by the presence or absence of aura. When headaches occur fewer than 15 days per month they are usually termed episodic migraine; when they occur on 15 or more days per month for more than three months, with at least eight days meeting migraine criteria, the condition is often labelled chronic migraine. Other recognised types include vestibular migraine (prominent balance or dizziness symptoms), hemiplegic migraine (temporary motor weakness), and ocular or retinal migraine when visual loss is a prominent feature. Diagnosis relies on clinical history and symptom pattern rather than a single laboratory test.
Causes and mechanisms
Current understanding frames migraine as a disorder of brain excitability and brain–blood vessel interactions. A variety of neural pathways and chemical mediators are involved; one peptide that has received substantial attention is calcitonin gene-related peptide (CGRP), which can promote vasodilation and neurogenic inflammation in tissues surrounding the brain, including the meninges. CGRP is not the sole cause of migraine but is an important mediator for many sufferers. Genetic susceptibility, environmental factors and changes in brain networks all contribute to the risk of developing recurrent attacks.
Triggers and risk factors
Many people with migraine identify specific triggers that tend to precede attacks. Common triggers include sleep disturbance, stress, dehydration, skipped meals, certain foods or additives, alcohol, strong odors, bright lights and changes in weather. For women, fluctuations in estrogen levels around menstruation or menopause can be a prominent trigger. Family history is a strong risk factor: migraine often runs in families, indicating inherited components. Lifestyle modification and trigger management are central parts of prevention strategies for many patients; see the list below for typical examples.
- Sleep regularity and hydration
- Stress reduction and pacing of activity
- Identification and avoidance of dietary triggers
- Consistent meal and caffeine patterns
Impact, treatment approaches and public health
Migraine is a leading cause of disability in working-age adults because attacks can be both frequent and disabling. The World Health Organization and other public health bodies have highlighted the substantial societal costs of migraine care and lost productivity. In regional and policy discussions it has been described as among the most costly neurological problems for treatment and disability in areas such as the World Health Organization-referenced literature; examples cited in reports include the European Union and the United States.
Management broadly divides into acute treatments to relieve individual attacks and preventive strategies to reduce attack frequency and severity. Acute care may use simple analgesics, antiemetics, or migraine-specific medications; preventive options include oral medications, neuromodulation devices, behavioural therapies, and, for many patients, newer therapies that target CGRP signalling. Decisions on treatment are personalised, based on attack frequency, side effects, coexisting medical conditions and patient preference.
People should seek medical advice if headaches are new, change in pattern, are unusually severe, or are accompanied by neurological symptoms that persist beyond the typical aura. Prompt assessment helps to exclude secondary causes and to establish an effective management plan that reduces disability and improves quality of life. For general background on headache disorders and symptom descriptions see resources on headache and public health summaries of risk factors.
Questions and answers
Q: What is a migraine?
A: A migraine is a medical condition which usually causes a pounding, throbbing headache on one side of the head. The pain may be very bad and hurt so much that a person may have a hard time doing anything. While most people who have migraines get a headache, not everyone does. There are different kinds of migraines, and some do not cause a headache but do have other symptoms. Most migraines cause a headache and nausea and might make the person dizzy or very sensitive to bright lights or loud noises.
Q: What are "auras"?
A: Auras are changes in vision that some people experience before they start having migraine headaches. They may see funny patterns, have blurry vision, or may not be able to see at all. Other senses can change before or during a migraine as well, and the person may sense funny smells or tastes.
Q: How long do migraines last?
A: Migraines usually last between four and 72 hours.
Q: What is the difference between episodic migraine (EM) and chronic migraine (CM)?
A: Episodic migraine (EM) occurs when someone has had fewer than 15 days with headaches in any given month whereas chronic migraine (CM) occurs when someone has had more than 15 days with headaches in any given month over an extended period of time. Some people who start off getting episodic migraines may start to get chronic migraines later on as well.
Q: What is CGRP?
A: CGRP stands for "calcitonin gene-related peptide". It's a protein that causes inflammation around the brain which leads to migraines when it is released around the brain area.
Q: Are there any risk factors associated with having migraines?
A: Yes, being female is one risk factor as well as having family members who had/have migraines previously/currently also increases your chances of developing them yourself too.
Q: Are there any trigger factors associated with getting migraines?
A: Yes, for females in particular one main trigger factor appears to be when their estrogen levels either drop too low or fluctuate up and down quickly over short periods of time
Related articles
Author
AlegsaOnline.com Migraine: symptoms, causes, types, and management Leandro Alegsa
URL: https://en.alegsaonline.com/art/64788
Sources
- who.int : World Health Organisation Factsheet No 277
- ncbi.nlm.nih.gov : PMID 19245386
- oxforddictionaries.com : "scotoma"
- doi.org : 10.1007/s10194-005-0240-8
- lyceumbooks.com : Boyle SW, Church II WT, Byrnes E: Migraine Headaches and Anger
- ncbi.nlm.nih.gov : PMID 22683712
- merriam-webster.com : "Differential diagnosis"
- merriam-webster.com : Comorbid | Definition of Comorbid by Merriam-Webster
- merriam-webster.com : merriam-webster.com
- merriam-webster.com : complication
- merriam-webster.com : epidemiology
- ncbi.nlm.nih.gov : PMID 11770192